Phase II study of carboplatin and 1-h intravenous etoposide and paclitaxel in a novel sequence as first-line treatment of patients with small-cell lung cancer

Lung Cancer ◽

10.1016/s0169-5002(02)00387-2 ◽

2003 ◽

Vol 39 (1) ◽

pp. 77-84 ◽

Author(s):

J.M Vieitez ◽

M Valladares ◽

M Gracia ◽

M Gonzalez-Barón ◽

G Martı́n ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Line Treatment ◽

Small Cell Lung ◽

First Line Treatment

Download Full-text

O-279 A multicenter randomised phase II study of cisplatin, etoposide, gemcitabine (PEG) versus cisplatin, gemcitabine (PG) as first line treatment in patients with small cell lung cancer (SCLC): Preliminary results

Lung Cancer ◽

10.1016/s0169-5002(03)91937-4 ◽

2003 ◽

Vol 41 ◽

pp. S81-S82

Author(s):

Filippo De Marinis ◽

Cesare Gridelli ◽

Marco Lombardo ◽

Luca Paoluzzi ◽

Francisco Ferraù ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Line Treatment ◽

Small Cell Lung ◽

First Line Treatment

Download Full-text

A phase II study of erlotinib as first-line treatment of advanced non-small cell lung cancer

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.7073 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 7073-7073 ◽

Author(s):

G. Giaccone ◽

T. Lechevalier ◽

N. Thatcher ◽

E. Smit ◽

M. Janmaat ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Line Treatment ◽

Small Cell Lung ◽

First Line Treatment

Download Full-text

Phase II study of docetaxel and cisplatin in first line treatment of disseminated small cell lung cancer (SCLC): preliminary results

European Journal of Cancer ◽

10.1016/s0959-8049(99)81461-0 ◽

1999 ◽

Vol 35 ◽

pp. S262

Author(s):

J.A. Moreno ◽

P. Lianes ◽

F. Cardenal ◽

I. Sevilla ◽

R. Garcia ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Line Treatment ◽

Small Cell Lung ◽

First Line Treatment

Download Full-text

9149 Phase II study of bevacizumab in combination with cisplatin and docetaxel as first line treatment of patients (p) with metastatic non squamous non-small-cell lung cancer (NSCLC)

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(09)71862-2 ◽

2009 ◽

Vol 7 (2) ◽

pp. 550

Author(s):

N. Ferrer ◽

M. Cobo ◽

A. Paredes ◽

M. Méndez ◽

J. Muñoz-Langa ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Line Treatment ◽

Small Cell Lung ◽

First Line Treatment

Download Full-text

Phase II study of liposomal cisplatin (Lipoplatin™) plus gemcitabine versus cisplatin plus gemcitabine as first line treatment in inoperable (stage IIIB/IV) non-small cell lung cancer

Lung Cancer ◽

10.1016/j.lungcan.2009.06.017 ◽

2010 ◽

Vol 68 (2) ◽

pp. 240-247 ◽

Author(s):

N. Mylonakis ◽

A. Athanasiou ◽

N. Ziras ◽

J. Angel ◽

A. Rapti ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Line Treatment ◽

Small Cell Lung ◽

First Line Treatment

Download Full-text

Phase II Study of Paclitaxel, Carboplatin, and Cetuximab as First Line Treatment, for Patients with Advanced Non-small Cell Lung Cancer (NSCLC): Results of OPN-017

Journal of Thoracic Oncology ◽

10.1097/jto.0b013e318189f50e ◽

2008 ◽

Vol 3 (11) ◽

pp. 1286-1292 ◽

Author(s):

Hossein Borghaei ◽

Corey J. Langer ◽

Michael Millenson ◽

Karen J. Ruth ◽

Samuel Litwin ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Line Treatment ◽

Small Cell Lung ◽

First Line Treatment

Download Full-text

A phase II study of biweekly carboplatin (Cb) and gemcitabine (G) with bevacizumab (B) as first-line treatment in patients with advanced, inoperable stage IIIb/IV non-squamous non-small cell lung cancer (NSCLC).

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.e18091 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. e18091-e18091

Author(s):

S. Bommakanti ◽

T. Larson ◽

A. Dudek ◽

J. Koopmeiners ◽

P. Kumar

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Line Treatment ◽

Small Cell Lung ◽

First Line Treatment

Download Full-text

A phase II study of erlotinib in combination with bevacizumab versus chemotherapy plus bevacizumab in the first-line treatment of advanced non-squamous non-small cell lung cancer

Lung Cancer ◽

10.1016/j.lungcan.2013.08.002 ◽

2013 ◽

Vol 82 (2) ◽

pp. 276-281 ◽

Author(s):

T. Ciuleanu ◽

C.-M. Tsai ◽

C.-J. Tsao ◽

J. Milanowski ◽

D. Amoroso ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Line Treatment ◽

Small Cell Lung ◽

First Line Treatment

Download Full-text

815 Elderly patients (pts) with unresectable localised or metastatic non-small-cell-lung-cancer (NSCLC): results of a phase II study with oral navelbineâ (nvb) given as a weekly monotherapy and first line treatment

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(03)90840-8 ◽

2003 ◽

Vol 1 (5) ◽

pp. S244-S245

Author(s):

U. Gatzemeier ◽

F. De Marinis ◽

C. Manegold ◽

P. Mali ◽

L. Portalone ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Line Treatment ◽

Small Cell Lung ◽

First Line Treatment

Download Full-text

First line treatment of advanced non-small cell lung cancer with doxetaxel and cis-platin: A multicenter phase II study

European Journal of Cancer ◽

10.1016/s0959-8049(97)85866-2 ◽

1997 ◽

Vol 33 ◽

pp. S236 ◽

Author(s):

N. Androulakis ◽

C. Kourousis ◽

S. Kakolyris ◽

A.M. Dimopoulos ◽

E. Papadakis ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Line Treatment ◽

Small Cell Lung ◽

Multicenter Phase ◽

First Line Treatment

Download Full-text